Glimipride 2 mg and Metformin ( sr ) 100 mg Voglibose 0.3 m
Packaging Size
10 Tablets
Manufactured By
ARLAK
Brand
CORAVOG GM3 FORTE
Packaging Type
Box
Country of Origin
Made in India
Brand Name :- Coravog GM2 FORTE Composition :- Glimipride 2 mg and Metformin ( sr ) 1000 mg Voglibose 0.3 mg Packing :- 10 x 10 Mrp :- 1900
MEDICATION USED FOR
This is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents the blood glucose levels from rising to very high levels after meals.
Ticazon- A Combikit is a combination of two medicines. It is used to prevent heart attacks. It works by preventing platelets from sticking together. This lowers the formation of harmful blood clots and lowers the risk of a heart attack.
Ticazon- A Combikit may be used alone or in combination with other medicines. It can be taken with or without food. Take it regularly and at the same time each day to get maximum benefits. It is important to keep taking this medicine even if you feel well. If you stop taking the medicine, it may increase your chance of having a heart attack.
Request Callback
Yes! I am Interested
Evening Primrose Oil 1000mg natural vitamin E 150mg (MOROSE-E-1000)
Ticagrelor is indicated to reduce the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction.6 Ticagrelor is also indicated to reduce the risk of a first myocardial infarction or stroke in high risk patients with coronary artery disease